Effect of single rectal dose of Misoprostol prior to abdominal hysterectomy in women with symptomatic leiomyoma: a randomized double blind clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20151011001

Enrollment

Registered

2015-10-11

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal hysterectomy bleeding volume Misoprostol Misoprostol bleeding volume abdominal hysterectomy

Interventions

400 micrograms rectal Misoprostol was administered to cases 30 minutes prior to operation. ,The controls received placebo in return.

Experimental Drug,Placebo Comparator Drug

intervention roup,control

Eligibility

Sex/Gender

Female

Age

0 Years to 0 Years

Inclusion criteria

Inclusion criteria: uterine myoma candidate for abdominal hysterectomy

Exclusion criteria

Exclusion criteria: emergency condition

Design outcomes

Primary

Measure	Time frame
bleeding 0 litr	—

Secondary

Measure	Time frame
age 0 year	—

Countries

iran

Contacts

Public Contactpouria yazdian

student research committee, shahid sadoughi university of medical sciences

pouria_yazdian_a@yahoo.com09385101025

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026